Antimicrobial stewardship leads from inpatient point prevalence surveillance of a tertiary-level care hospital

Main Article Content

Shabaz Mohiuddin Gulam
Dixon Thomas
Fiaz Ahamed
Danial E. Baker

Keywords

Antimicrobial Stewardship, United Arab Emirates , Pilot study, Tertiary-level Care

Abstract

Background: To explore the scope of antimicrobial stewardship activities based on the point prevalence study of antimicrobials among hospitalized patients in a tertiary-level care hospital in the UAE. Methods: A single-center cross-sectional prevalence study was conducted among inpatients admitted to a tertiary care hospital using the European Surveillance of Antimicrobial Consumption tool in February 2023. Antimicrobials used against bacteria only were surveyed. All patients admitted to the selected departments at 8 AM on the day of the survey were included. Data were described in numbers and percentages. Results: Among 136 patients admitted at the time of the study, 87 received antimicrobials, representing a prevalence of 64%. A total of 144 antimicrobial prescriptions were prescribed in 87 patients. The majority of the antimicrobials were administered parenterally (n=122, 84.7%), and over 60% (n=53) of the patients on antimicrobials received two antimicrobials. The majority of antimicrobials used for therapy were empiric in nature (n=68, 89.5%). Over half of the patients receiving antimicrobials for surgical prophylaxis were prescribed antimicrobials for two or more days. More than 60% of the antimicrobial orders were adherent to the hospital guidelines. Conclusion: The point prevalence of the use of antimicrobials is high, which highlights the need for more efficient and targeted stewardship efforts in improving adherence with the hospital guidelines. Wide usage of broad-spectrum antimicrobials is observed.

Abstract 205 | PDF Downloads 124

References

1. Al-Kaabi MR, Tariq WU, Hassanein AA. Rising bacterial resistance to common antibiotics in Al Ain, United Arab Emirates. East Mediterr Health J. 2011;17(6):479-84.
2. Aly M, Balkhy HH. The prevalence of antimicrobial resistance in clinical isolates from Gulf Corporation Council countries. Antimicrob Resist Infect Control. 2012;1(1):26.
3. Dadgostar P. Antimicrobial Resistance: Implications and Costs. Infect Drug Resist. 2019;12:3903-3910.
4. Centers for Disease Control and Prevention. Antibiotic Resistance Threats in the United States, 2019. Accessed August 26, 2023. Available from: https://www.cdc.gov/drugresistance/pdf/threats-report/2019-ar-threats-report-508.pdf.
5. World Health Assembly. Global action plan on antimicrobial resistance, 2015. Accessed September 01, 2023. Available from:
https://apps.who.int/gb/ebwha/pdf_files/WHA68/A68_R7-en.pdf.
6. World Health Organization. United Arab Emirates: National strategy and action plan for combatting antimicrobial resistance (NAP-AMR), 2019. Accessed September 01, 2023. Available from: https://www.who.int/publications/m/item/united-arabemirates-
national-strategy-and-action-plan-for-combatting-antimicrobial-resistance-(nap-amr).
7. Llor C, Bjerrum L. Antimicrobial resistance: risk associated with antibiotic overuse and initiatives to reduce the problem. Ther Adv Drug Saf. 2014;5(6):229-41.
8. World Health Organization. WHO methodology for point prevalence survey on antibiotic use in hospitals. World Health Organization; 2018. Accessed September 01, 2023. Available from: https://www.who.int/publications/i/item/WHO-EMPIAU-2018.01
9. Vandael E, Latour K, Goossens H, Magerman K, Drapier N, Catry B, Versporten A; Belgian Point Prevalence Survey Study Group. Point prevalence survey of antimicrobial use and healthcare-associated infections in Belgian acute care hospitals: results of the
Global-PPS and ECDC-PPS 2017. Antimicrob Resist Infect Control. 2020;9(1):13.
10. Magill SS, Edwards JR, Beldavs ZG, Dumyati G, Janelle SJ, Kainer MA, Lynfield R, Nadle J, Neuhauser MM, Ray SM, Richards K, Rodriguez R, Thompson DL, Fridkin SK; Emerging Infections Program Healthcare-Associated Infections and Antimicrobial Use
Prevalence Survey Team. Prevalence of antimicrobial use in US acute care hospitals, May-September 2011. JAMA. 2014 Oct 8;312(14):1438-46.
11. Alnajjar MS, Jawhar DS, Aburuz S, Saeed DA, Ibrahim AH. Point prevalence survey of antibiotic utilization in secondary care hospital in the United Arab Emirates. Pharm Pract (Granada). 2022;20(3):2685.
12. Aldeyab MA, Kearney MP, McElnay JC, Magee FA, Conlon G, Gill D, Davey P, Muller A, Goossens H, Scott MG; ESAC Hospital Care Subproject Group. A point prevalence survey of antibiotic prescriptions: benchmarking and patterns of use. Br J Clin
Pharmacol. 2011;71(2):293-6.
13. Elhajji FD, Al-Taani GM, Anani L, et al. Comparative point prevalence survey of antimicrobial consumption between a hospital in Northern Ireland and a hospital in Jordan. BMC Health Serv Res. 2018;18(1):849.
14. Al Matar M, Enani M, Binsaleh G, et al. Point prevalence survey of antibiotic use in 26 Saudi hospitals in 2016. J Infect Public Health. 2019;12(1):77-82.
15. Alsaeed OM, Bukhari AA, Alshehri AA, et al. The Use of Antibiotics for the Prevention of Surgical Site Infections in Two Government Hospitals in Taif, Saudi Arabia: A Retrospective Study. Cureus. 2022; 11;14(7):e26731.
16. Ahmed N, Balaha M, Haseeb A, Khan A. Antibiotic usage in surgical prophylaxis: A retrospective study in the surgical ward of a governmental hospital in Riyadh region. Healthcare (Basel). 2022 Feb 18;10(2):387.
17. Alshehhi HS, Ali AA, Jawhar DS, et al. Assessment of implementation of antibiotic stewardship program in surgical prophylaxis at a secondary care hospital in Ras Al Khaimah, United Arab Emirates. Sci Rep. 2021 Jan 13;11(1):1042.
18. El Hassan M, Elnour AA, Farah FH, et al. Clinical pharmacists’ review of surgical antimicrobial prophylaxis in a tertiary hospital in Abu Dhabi. Int J Clin Pharm. 2015 Feb;37(1):18-22.
19. Abdel-Aziz A, El-Menyar A, Al-Thani H, et al. Adherence of surgeons to antimicrobial prophylaxis guidelines in a tertiary general hospital in a rapidly developing country. Adv Pharmacol Sci. 2013;2013:842593.
20. Tolba YY, El-Kabbani AO, Al-Kayyali NS. An observational study of perioperative antibiotic-prophylaxis use at a major quaternary care and referral hospital in Saudi Arabia. Saudi J Anaesth. 2018;12(1):82-88.
21. Alkaabi MS, Harun SN, Sha’aban A. Evaluation of the Impact of Antibiotic Stewardship Program on Antibiotics Utilization As Surgical Prophylaxis at a Secondary Hospital in United Arab Emirates. Accessed September 13, 2023. Available from: https://
scholarworks.uaeu.ac.ae/cgi/viewcontent.cgi?article=1059&context=healthmed_research_conference
22. Jamaluddin NA, Periyasamy P, Lau CL, et al. Point prevalence survey of antimicrobial use in a Malaysian tertiary care university hospital. Antibiotics (Basel). 2021;10(5):531.